Polycythemia and oxygen sensing

Pathologie Biologie

Volumn 52, Issue 5, 2004, Pages 280-284

  Maran, Jey ^a   Prchal, Josef ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

BFU E; CFU E; Chuvash polycythemia; Polycyth mia vera (PV); Polycythemia Vera (PV); Polyglobulie de Vaquez; Polyglobulie primitive cong nitale et familiale; Primary Familial Congenital Polycythemia (PFCF); Secondary polycythemia

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BIPHOSPHOGLYCEROMUTASE; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; HEMOGLOBIN; HYPOXIA INDUCIBLE FACTOR 1; LOSARTAN; MUTASE; NEUTRALIZING ANTIBODY; NUCLEOTIDE; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ALLELE; APOPTOSIS; AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE INHERITANCE; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CELL PROLIFERATION; CHUVASH POLYCYTHEMIA; CONFERENCE PAPER; CYTOPLASM; ENZYME DEFICIENCY; ERYTHROCYTE; ERYTHROCYTOSIS; ERYTHROID CELL; ERYTHROPOIESIS; GENE DELETION; GENE EXPRESSION; GENE MUTATION; HEMATOPOIETIC STEM CELL; HUMAN; HYPERSENSITIVITY; KIDNEY TRANSPLANTATION; MISSENSE MUTATION; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN DISSOCIATION CURVE; POLYCYTHEMIA; POLYCYTHEMIA VERA; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TISSUE OXYGENATION;

ERYTHROCYTES; HEMATOPOIETIC STEM CELLS; HUMANS; OXYGEN; OXYGEN CONSUMPTION; POLYCYTHEMIA;

EID: 3042519411     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2004.02.006     Document Type: Conference Paper

References (28)

1. Prchal J.T. Classification and molecular biology of polycythemias (erythrocytoses) and thrombocytosis. Hematol Oncol Clin North Am. 17:(5):2003;1151-1158
2. Ania B.J., Suman V.J., Sobell J.L., Codd M.B., Silverstein M.N., Melton L.J. III. Trends in the incidence of polycythemia vera among Olmsted County, Minnesota residents, 1935-1989. Am J Hematol. 47:(2):1994;89-93
3. Berlin N.I. Diagnosis and classification of the polycythemias. Semin Hematol. 12:(4):1975;339-351
4. Spivak J.L. Polycythemia vera: myths, mechanisms, and management. Blood. 100:(13):2002;4272-4290
5. Prchal J.F., Axelrad A.A. Letter: bone-marrow responses in polycythemia vera. N Engl J Med. 290:(24):1974;1382
6. Fisher M.J., Prchal J.F., Prchal J.T., D'Andrea A.D. Anti-erythropoietin (EPO) receptor monoclonal antibodies distinguish EPO-dependent and EPO-independent erythroid progenitors in polycythemia vera. Blood. 84:(6):1994;1982-1991
7. Prchal J.T., Divoky V. Lessons to better understanding of hypoxia sensing: acquired and congenital mutations resulting in polycythemia. Adv Exp Med Biol. 502:2001;189-205
8. Kralovics R., Prchal J.T. Genetic heterogeneity of primary familial and congenital polycythemia. Am J Hematol. 68:(2):2001;115-121
9. Constantinescu S.N., Keren T., Socolovsky M., Nam H., Henis Y.I., Lodish H.F. Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain. Proc Natl Acad Sci USA. 98:(8):2001;4379-4384
10. Witthuhn B., Quelle F., Silvennoinen O., Ui T., Tang B., Miura O., et al. JAK2 associate with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell. 74:1993;227-238
11. Arcasoy M.O., Harris K.W., Forget B.G. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation. Exp Hematol. 27:(1):1999;63-74
12. Jedlickova K., Stockton D.W., Prchal J.T. Possible primary familial and congenital polycythemia locus at 7q22.1-7q22.2. Blood Cells Mol Dis. 31:(3):2003;327-331
13. Divoky V., Liu Z., Ryan T.M., Prchal J.F., Townes T.M., Prchal J.T. Mouse model of congenital polycythemia: homologous replacement of murine gene by mutant human erythropoietin receptor gene. Proc Natl Acad Sci USA. 98:(3):2001;986-991
14. Lichtman M.A., Murphy M.S., Adamson J.W. Detection of mutant hemoglobins with altered affinity for oxygen. A simplified technique. Ann Intern Med. 84:(5):1976;517-520
15. Prchal J.T., Gregg X. Red cell enzymopathies. 3rd ed Hoffmann R. Hematology. 1999;561-576 WB Saunders, Philadelphia
16. Poliakova L.A. Familial erythrocytosis among the residents of the Chuvash ASSR. Probl Gematol Pereliv Krovi. 19:(10):1974;30-33
17. Sergeyeva A., Gordeuk V.R., Tokarev Y.N., Sokol L., Prchal J.F., Prchal J.T. Congenital polycythemia in Chuvashia. Blood. 89:(6):1997;2148-2154
18. Ang S.O., Chen H., Gordeuk V.R., Sergueeva A.I., Polyakova L.A., Miasnikova G.Y., et al. Endemic polycythemia in Russia: mutation in the VHL gene. Blood Cells Mol Dis. 28:(1):2002;57-62
19. Ang S.O., Chen H., Hirota K., Gordeuk V.R., Jelinek J., Guan Y., et al. Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet. 32:(4):2002;614-621
20. Gordeuk V.R., Sergueeva A.I., Miasnikova G.Y., Okhotin D.J., Prchal J.T., Polyakova L.A. High Mortality due to thrombosis and cerebral hemorrhage in Chuvash polycythemia. Blood. 98:2001;224a
21. Pastore Y., Jedlickova K., Guan Y., Liu E., Fahner J., Hasle H., et al. Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia. Am J Hum Genet. 73:(2):2003;412-419
22. Percy M.J., McMullin M.F., Jowitt S.N., Potter M., Treacy M., Watson W.H., et al. Chuvash-type congenital polycythemia in 4 families of Asian and Western European ancestry. Blood. 102:(3):2003;1097-1099
23. Pastore Y.D., Jelinek J., Ang S., Guan Y., Liu E., Jedlickova K., et al. Mutations in the VHL gene in sporadic apparently congenital polycythemia. Blood. 101:(4):2003;1591-1595
24. Liu E., Percy M.J., Amos C.I., Guan Y., Shete S., Stockton D.W., et al. The worldwide distribution of the VHL 598C>T mutation indicates a single founding event. Blood. 103:(5):2004;1937-1940
25. Corn P.G., McDonald E.R. III, Herman J.G., El-Deiry W.S. Tat-binding protein-1, a component of the 26S proteasome, contributes to the E3 ubiquitin ligase function of the von Hippel-Lindau protein. Nat Genet. 35:(3):2003;229-237
26. Julian B.A., Brantley R.R. Jr, Barker C.V., Stopka T., Gaston R.S., Curtis J.J., et al. Losartan, an angiotensin II type 1 receptor antagonist, lowers hematocrit in posttransplant erythrocytosis. J Am Soc Nephrol. 9:(6):1998;1104-1108
27. Mrug M., Stopka T., Julian B.A., Prchal J.F., Prchal J.T. Angiotensin II stimulates proliferation of normal early erythroid progenitors. J Clin Invest. 100:(9):1997;2310-2314
28. Maran J., Jedlickova K., Stockton D.W., Prchal J.T. Finding the novel molecular defect in a family with high erythropoietin autosomal dominant polycythemia. Blood. 102:(11):2003;4359